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ABSTRACT
This paper describes a Bayesian statistical method for determining the ge-
netic basis of a complex genetic trait. The method uses a sample of unrelated
individuals classified into two groups, for example cases and controls. Each group
is assumed to have been genotyped at a battery of marker loci using a labora-
tory effort efficient technique called DNA pooling. The aim is to detect and
map a quantitative trait locus (QTL) that is not one of the typed markers. The
method works by conducting an exact Bayesian analysis under a number of sim-
plifying population genetic assumptions that are somewhat unrealistic. Despite
this, the method is shown to perform acceptably on datasets simulated under
a more realistic model, and furthermore is shown to outperform classical single
point methods.
1. Introduction
For many traits of interest, including susceptibility to many genetic diseases, the genetic
basis is complex, meaning that many genes of individually small effect (quantitative trait loci;
QTLs) contribute. For detecting and mapping such QTLs, association mapping studies that
use large samples of essentially unrelated individuals may have two advantages over linkage
studies that use pedigrees or families: For a given sample size, association studies may have
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– 2 –
more power to detect a QTL (e.g. Risch and Merikangas 1996, Risch 2000), and they may
allow the QTL to be fine mapped with greater resolution or precision (e.g. Terwilliger 1995,
McPeek and Strahs 1999). One important experimental design is a genome wide scan, in
which many thousands of markers covering the whole genome are typed (see e.g. Lander
1996, Risch and Merikangas 1996, Kruglyak 1999, Carlson et al. 2003). The aim may be to
detect QTL that are not candidate genes and that have escaped detection in linkage studies.
After preliminary analysis, attention may focus on relatively small chromosomal regions,
each containing perhaps only one QTL. Because of nongenetic factors and the effects of
other genetically distant QTLs, each focal QTL will explain only a small fraction of the
variance in phenotype. If the trait is binary (such as presence or absence of a disease), the
difference in QTL allele frequencies between the two trait groups will be small. The large
numbers of markers required for a genome wide scan will need to have been typed in large
numbers of individuals to detect such a QTL, and to infer its position, frequency, and effect
on the trait.
In order to reduce the cost of such a study, an experimental strategy called DNA pooling
has been proposed (e.g Arnheim et al. 1985, Barcellos et al. 1997, Sham et al. 2002, Norton
et al. 2004). Here DNA from individuals with similar phenotypes is physically mixed together
into a pool before genotyping. After overheads to do with construction of pools and assay
development, the cost of genotyping an entire pool at a given marker is reduced to the cost of
genotyping a single individual. Thus costs may be reduced by a factor close to the number of
individuals in a pool (divided by the number of experimental replicates used for each pool),
when the overheads can be spread across many markers and across many disease studies.
In this paper I consider the simplest experimental design where there are two trait
groups. These could have been classified by the presence or absence of binary trait such
as a disease. Alternatively, if the trait is quantitative, individuals from each tail of the
trait distribution could make up the two groups, for example the upper and lower 10% tails
(e.g. Darvasi and Soller 1994, Bader et al. 2001). For simplicity I will refer throughout the
paper to the two trait groups as cases and controls, and to one of the alleles at the QTL
as the disease allele. I note that data collected from more than two groups can be analysed
using the method developed here, by discarding or combining data from some of the groups.
(An extreme example is where each pool contains two chromosomes, i.e. genotype data are
available.) Such an approach is valid and may be useful, but will almost certainly not make
most efficient use of the available data, since it will be based on only a marginal observation
that is almost certainly not sufficient.
Compared with individual genotyping, a DNA pooling strategy incurs three types of
information loss and error. At each marker only the marginal counts of the alleles present
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within each pool are are available, and so there is (i) no information about deviations from
Hardy–Weinberg proportions within each marker within each pool (Risch and Teng 1998)
and (ii) no information about phase or linkage information across markers within each pool
(Johnson 2005). Further (iii), the marginal counts are only estimated from some kind of
quantitative genotyping experiment (e.g. Germer et al. 2000, Le Hellard et al. 2002), rather
than by counting individual genotyping experiments.
The present approach deals with (iii) by allowing a quite general class of models for
errors in allele frequency estimation. It attempts to deal with (i) and (ii) by using the full
likelihood given the available data. This likelihood does however assume a model that makes
simplifying assumptions that are not as realistic as one would like. This may be an acceptable
price to pay, because it allows all the necessary computations to be done analytically or using
simple numerical algorithms. The aim is to develop a method that can be used on very large
data sets, with hundreds of cases and hundreds of controls typed at hundreds of markers.
The simple model used here is a special case of the model introduced by McPeek and
Strahs (1999) and studied by Morris et al. (2000), Zhang and Zhao (2000, 2002) and Liu et al.
(2001) for haplotype and genotype data. In brief summary, I assume a unique mutation event
(perhaps a single nucleotide polymorphism, or a deletion) generated the disease allele at the
disease QTL, that there is a star shaped genealogy since that mutation, that the disease
allele is absent from the control group, and that Hardy–Weinberg and linkage equilibrium
apply in the control group.
Avoiding the use of more complicated algorithms such as Markov chain Monte Carlo
(MCMC) means that there are no concerns about mixing and convergence, and no difficul-
ties with computing normalising constants and Bayes factors for model testing and model
comparison. When the model is correct, the Bayes factor is (in various classical senses,
see O’Hagan and Forster 2004 ch.5) an optimal test statistic for detecting a QTL (see also
Patterson et al. 2004). Therefore the present approach can be viewed as choosing an approx-
imate model that is simple enough to allow an exact and optimal analysis. It will therefore
complement alternative approaches that perform approximate or sub-optimal analyses for
more realistic models.
One example of such an alternative approach is to perform a classical single point
analysis, which applies a separate test to the data for each marker. Such an approach can be
made essentially free of any population genetic model, meaning that no worring assumptions
are made but also that there is no efficient framework for combining analyses across many
markers (e.g. to correct for multiple testing). When genotype data are available and when
the QTL is not one of the typed markers, such single point methods are known to lack power
(e.g. Risch 2000, Mott et al. 2000, Zollner and Pritchard 2005), and may produce inefficient
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point estimates and inefficiently large region estimates for the position of the QTL (e.g.
Morris et al. 2002, 2003).
One justification for the method developed here is that although the model is simple,
it is to my knowledge the most complex model for which a Bayesian analysis has been
implemented using data from DNA pools. To provide further justification and reassurance
about the simplifying assumptions made, I have tested the method on data simulated under
a more realistic full coalescent model. The (necessarily classical) measures of performance
are encouraging in three respects. Firstly, the power to detect a QTL is substantially higher
than for classical single point analysis. Secondly, point estimates for the position of the
QTL derived from the present method outperform the simple procedure of choosing the
map position of the marker with the most significant single point test result (the “minimum
p-value method”, e.g. Kaplan and Morris 2001a,b). Thirdly, after “flattening” the posterior
using a factor (derived by McPeek and Strahs 1999) that corrects for the fact that the true
genealogy is not in fact star shaped, credibility intervals for the position of the QTL cover its
true position with frequency equal to their nominal size. That is, they are well calibrated.
The structure of this paper is as follows. In section 2 I review the model introduced
by McPeek and Strahs (1999), for which an exact Bayesian analysis can be performed using
multilocus estimated allele frequency data, collected using DNA pools. In section 3 I describe
in detail how the computations for such an analysis are performed. In section 4 I review a
more realistic coalescent model that I have used to generate simulated data sets on which to
test the current approach. In section 5 I describe the performance of the method developed
in sections 2–3 on those simulated data sets. In section 6 I summarise the results and discuss
how the method could be improved.
2. The Simplified Model and Prior
The main notations and abbreviations used are listed in table 1, and the conditional
independencies of the variables are represented in figure 1.
I assume the data (collectively denoted yˆ) consist of allele frequency estimates at L single
nucleotide polymorphisms (SNPs), obtained from a single pool of nd case chromosomes and
a single pool of nc control chromosomes. Let mi be the known map position of the i-th SNP.
Let the alleles at each SNP be arbitrarily labelled 0 and 1, with yˆd,i(1) ≡ nd − yˆd,i(0) the
estimated count of the 1 allele at the i-th SNP in the cases, and yˆc,i(1) ≡ nc − yˆc,i(0) the
estimated count of the 1 allele at the i-th SNP in the controls. When there is no ambiguity,
yˆ will mean the estimated count of the 1 allele at some SNP in some pool that is to be
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inferred from the context. (This can easily be generalised to let yˆd,i be arbitrary vector
valued information about the counts of the two alleles at the i-th SNP in the cases, etc.)
The method may be generalised to allow more than two alleles at each marker.
Let yd,i(1) and yc,i(1) be the true counts of the 1 allele at the i-th SNP in the cases and in
the controls respectively. I assume that an error model Pr (yˆd,i, yˆc,i|yd,i, yc,i) has been chosen
and parameterised, for example from a calibration data set consisting of pairs (yˆ, y) that were
obtained from a given set of individuals by genotyping them as a pool and by genotyping
them individually. Note that the error model cannot be factorised unless we assume that
the errors in the case and control pools are unconditionally independent. However, we may
believe that the data were obtained using assays that vary in precision across SNPs. Letting
ei indicate the unknown precision of the assay used for the i-th SNP, we could model these
beliefs as
Pr (yˆd,i, yˆc,i|yd,i, yc,i) =
∑
ei
Pr (yˆd,i|yd,i, ei) Pr (yˆc,i|yc,i, ei) Pr (ei) , (1)
that is, the error distribution is modelled as a mixture distribution where each component of
the mixture factorises. In the following, reasonable flexibility in the nature of this error model
is allowed: the errors must be independent across SNPs but they need not be independent
across pools and they do not need to be identically distributed across SNPs. A example
error model is given in section 4.
Let the unknown map position of the disease QTL relative to the leftmost marker SNP
be µ; often this will be the variable of main interest. I allow any prior Pr (µ); obvious choices
would be a uniform density on physical distance, or one based on known gene density (see
e.g. Rannala and Reeve 2001). I assume a unique mutation event generated the disease allele
at the disease QTL, so some number of haplotypes (xµ) in the case pool carry the disease
allele and are identical by descent (i.b.d.) at this position. I assume xµ ∼ Bin (nd, ρ) for a
rate ρ, and since ρ itself is uncertain I assume a beta prior with parameter R = (R1, R0), so
the prior mean is R1/(R0 + R1). Specifying (R1, R0) = (1, 1) specifies a flat prior on [0, 1]
for ρ. I assume that the disease allele is absent from the control pool. The adequacy of
this approximation, and ways in which it could be relaxed, are taken up in the discussion in
section 6.
Each disease allele is embedded in a block of i.b.d. haplotype, the “ancestral haplotype”,
with breakpoints at distances dL and dR to the left and right of the position of the QTL.
I assume a star shaped genealogy for the disease allele, so that dL and dR for all blocks of
ancestral haplotype are conditionally independent and identically distributed (i.i.d.) from an
exponential distribution with mean 1/τ Morgans, where τ is the age of the disease allele in
generations and distances are measured in Morgans (McPeek and Strahs 1999, see also Morris
et al. 2000, Zhang and Zhao 2000, 2002, Liu et al. 2001). (The left and right breakpoints
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are the positions of the nearest crossovers in τ meioses where crossovers occur as a Poisson
process with rate 1.) I allow any prior Pr (τ); lognormal and gamma are reasonable choices.
Specifying an exponential prior with sufficiently small parameter T (so the prior mean 1/T is
sufficiently large) specifies a prior that is effectively flat over the region where the likelihood
is non-negligible. This has the effect of making the posterior model probability or Bayes
factor proportional to T . A crucial variable in the analysis is xi, the number of chromosomes
in the case pool that carry the i.b.d. haplotype at the i-th SNP. The assumptions above
specify a distribution for the xi. A key feature of the present method is that the xi are not
independent across SNPs, in constrast to what is assumed in composite likelihood methods
(e.g. Terwilliger 1995, Xiong and Guo 1997, Collins and Morton 1998, Maniatis et al. 2004,
2005).
All other non-i.b.d haplotype is called heterogenous “non-ancestral haplotype”. The
allele present in non-ancestral haplotype is assumed conditionally independent across chro-
mosomes within SNPs, and across SNPs within chromosomes, with πi(1) the probability of
a 1 allele at the i-th SNP and πi(0) ≡ 1 − πi(1). (This is equivalent to assuming Hardy–
Weinberg and linkage equilibrium in blocks of non-ancestral chromosome.) This assumption
is a very bad one when haplotype or genotype data are available (Liu et al. 2001, Morris et al.
2002, Li and Stephens 2003), but when only multilocus allele frequency data are available it
may be more innocuous; this assumption leads to a massive simplification in the likelihood.
I assume an independent beta prior for each πi(1), with parameter Pi = (Pi,1, Pi,0), so the
prior mean is Pi,1/(Pi,0 + Pi,1). The method should be robust to misspecification of Pi as
long as both elements are much smaller than nc.
The allele present on the ancestral haplotype at the position of the i-th SNP, ai, is
assumed to be a single draw from the same distribution as for a block of nonancestral
chromosome. That is, each ai is an independent Bernoulli variable with parameter πi(1).
3. Analysis
3.1. Overview
The purpose of the analysis is to compute the posterior distribution for quantities of
interest. Here I focus on computing the Bayes factor in favour of a model in which a
QTL is present, versus a model with no QTL. This Bayes factor allows the posterior model
probabilities to be computed for any prior on the two models. I also compute the posteriors
for µ, τ and ρ, given that a QTL is present, marginalising all other variables.
The model has a hierarchical structure as shown in figure 1. Note that the joint distri-
– 7 –
bution of the xi depends on µ, τ and ρ, but that the probability of the data at the i-th SNP
only depends on xi and other variables πi and ai for which the prior is independent across
SNPs. The first step of the analysis, in section 3.2, is to perform an independent calculation
for each SNP that integrates out πi and ai conditional on xi. The second step of the analysis,
in section 3.3, is to integrate out all the xi and xµ conditional on µ, τ and ρ. This gives the
posterior density for these three variables. The final step, in section 3.4, is to compute the
marginal posteriors for each of µ, τ and ρ, and the normalising constant or probability of
the data given models with and without a QTL.
3.2. Calculations for the i-th SNP
Note that all probabilities in this section are conditional on xi, the number of chro-
mosomes in the case pool carrying the ancestral i.b.d. chromosome. At the i-th SNP let
yd,i(1) ≡ nd − yd,i(0) be the (unknown) actual count of the 1 allele in cases, and yc,i(1) ≡
nc−yc,i(0) be the actual estimated count of the 1 allele in controls. Let yd,i = (yd,i(1), yd,i(0))
and a similar notation apply for controls. Under the modelling assumptions we have
Pr (yd,i|xi, ai, πi) = Bin (yd,i(ai)− xi, nd − xi, πi(ai)) (2)
Pr (yc,i|πi) = Bin (yd,i(1), nc, πi(1)) (3)
where Bin (x, n, p) is the probability of observing x successes in n independent trials with
success probability p (and understood to be zero unless 0 ≤ x ≤ n). For a more detailed
motivation of (2) and (3) see Johnson (2005 appendix A)
Then the probability of the observed data can be written
Pr (yˆd,i, yˆc,i|xi, ai, πi) =
∑
yd,i
∑
yc,i
Pr (yˆd,i, yˆc,i|yd,i, yc,i) Pr (yd,i|xi, ai, πi) Pr (yc,i|πi) . (4)
We can simplify at this stage by writing down the distribution marginal to ai and πi
and moving the respective sum and integral as far inside the expression as possible, to get
Pr (yˆd,i, yˆc,i|xi) =
∑
yd,i
∑
yc,i
(
Pr (yˆd,i, yˆc,i|yd,i, yc,i)
∫ ∑
ai
(
Pr (yd,i|xi, ai, πi) Pr (ai|πi)
)
Pr (yc,i|πi) Pr (πi)dπi
)
. (5)
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The innermost sum over ai can be rewritten
Pr (yd,i|xi, πi) =
∑
ai
Pr (yd,i|xi, ai, πi) Pr (ai|πi) (6)
=
∑
ai
(
Bin (yd,i(ai)− xi + 1, nd − xi + 1, πi(ai))
×
(
nd − xi
yd,i(ai)− xi
)/(
nd − xi + 1
yd,i(ai)− xi + 1
))
(7)
=
∑
ai
(
Bin (yd,i(ai)− xi + 1, nd − xi + 1, πi(ai))
×yd,i(ai)− xi + 1
nd − xi + 1
)
. (8)
This allows the integral over πi to be computed analytically when (as assumed above) the
prior Pr (πi(ai)) is a beta distribution with parameter (Pi,ai , Pi,1−ai)
Pr (yd,i, yc,i|xi) =
∫
Pr (yd,i|xi, πi) Pr (yc,i|πi) Pr (πi)dπi (9)
=
∑
ai
(
(nd − xi + 1)! Γ(nc + Pi,0 + Pi,1)
Γ(nd − xi + 1 + nc + Pi,0 + Pi,1)
×Γ(yd,i(ai)− xi + 1 + yc,i(ai) + Pi,ai)
(yd,i(ai)− xi + 1)! Γ(yc,i(ai) + Pi,ai)
×Γ(yd,i(1− ai) + yc,i(1− ai) + Pi,1−ai)
yd,i(1− ai)! Γ(yc,i(1− ai) + Pi,1−ai)
×yd,i(ai)− xi + 1
nd − xi + 1
)
(10)
Thus the probability of the observed data reduces to
Pr (yˆd,i, yˆc,i|xi) =
∑
yd,i
∑
yc,i
Pr (yˆd,i, yˆc,i|yd,i, yc,i) Pr (yd,i, yc,i|xi) (11)
where the first term in the summand is the error model and the second term is given by (10).
Because yˆd,i and yˆc,i are fixed and ai and πi have been integrated out, values of (11)
for each xi can be precomputed and stored in a small lookup table of size (nd + 1). It is
therefore feasible to use a complicated and hopefully realistic error distribution, as discussed
above. For many error models, computation can be speeded up without loss of accuracy by
judicious reduction of the range of the summation in (11).
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3.3. Hidden Markov Model for xµ and the xi
Throughout this section, all probabilities are conditional on given values of µ, τ and ρ
but to make a clearer exposition this is suppressed in the notation.
Assume for clarity of exposition that µ is a position within the battery of marker SNPs.
Let ⌈µ⌉ = min {i : mi ≥ µ} and ⌊µ⌋ = max {i : mi < µ} denote the indices of the SNPs to
the right and left of the QTL. The algorithm works with obvious modifications when µ is a
position outside the battery of marker SNPs.
Under the modelling assumptions, as we move away from the position of the disease
locus, the number of chromosomes containing i.b.d. ancestral chromosome, xi, is Markovian.
The transition probabilities of a (nonstationary and inhomogenous) hidden Markov model
(HMM; see e.g. Durbin et al. 1998 ch.3), for marker SNPs to the right of µ (i.e. ⌈µ⌉ ≤ i), are
Pr (xi+1|xi) = Bin (xi+1, xi, exp (−τ × (mi+1 −mi))) (12)
Similar equations hold for for marker SNPs to the left of µ, and for Pr (xi|xµ). The emmission
probabilities of the HMM are given by (11). There is an important difference between
this HMM and the HMMs of McPeek and Strahs (1999), Morris et al. (2000), Zhang and
Zhao (2000, 2002) and Liu et al. (2001). Those authors modelled the observed haplotypes
or genotypes as a set of conditionally independent HMMs, conditional on (in the present
notation) (a1, . . . , aL), (π1, . . . , πL) as well as µ, τ and ρ. Thus they had to use expensive
numerical algorithms (optimisation or MCMC) on the high dimensional space of variables
on which the HMMs were conditioned. Here I am able to model all the data as a single
HMM conditional on only µ, τ and ρ. I am thus able to integrate out the high dimensional
(a1, . . . , aL) and (π1, . . . , πL) using an efficient numerical algorithm and am left with only
a low dimensional space (the space for (µ, τ, ρ)) on which I will need to use an expensive
numerical algorithm.
We can use the backwards propagation algorithm for HMMs to sum over the hidden
states (x1, . . . , xL) (see e.g. Durbin et al. 1998 ch.3, Liu 2001 pp.28–31). Readers familiar
with HMMs may wish to skip the rest of this section.
Define the backwards variables for SNPs at positions to the right of the QTL
b(xi) := Pr (yˆd,i+1, yˆc,i+1, . . . , yˆd,L, yˆc,L|xi) (13)
and for SNPs at positions to the left of the QTL
b′(xi) := Pr (yˆd,1, yˆc,1, . . . , yˆd,i−1, yˆc,i−1|xi) (14)
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Here backwards is relative to the direction in which the hidden process is Markovian. Equa-
tion (14) should not be confused with a forwards variable, which are not used in this compu-
tation. Note also that the backwards variables are functions of which SNP (i) and the value
of that xi at that SNP, but that I have adopted a more streamlined notation that I hope is
unambiguous.
The backwards variables have the obvious interpretation when the arguments run out
of range, that
b(xL) := Pr (nothing|xL) = 1 (15)
b′(x1) := Pr (nothing|x1) = 1 (16)
Using (16) to initialise the backwards variables at i = L, we then proceed to propagate
leftwards along the chromosomes for each i = L−1, . . . , ⌈µ⌉ in turn, compute the backwards
variables for every (xi) using
b(xi) =
∑
xi+1
Pr (xi+1|xi) Pr (yˆd,i+1, yˆc,i+1|xi+1)b(xi+1) (17)
and then terminate the algorithm by computing
Pr (yˆd,⌈µ⌉, yˆc,⌈µ⌉, . . . , yˆd,L, yˆc,L|xµ) =
∑
x⌈µ⌉
Pr (x⌈µ⌉|xµ) Pr (yˆd,⌈µ⌉, yˆc,⌈µ⌉|x⌈µ⌉)b(x⌈µ⌉) (18)
for every xµ.
Likewise, using (16) to initialise the b′ backwards variables at i = 1 we can propagate
rightwards along the chromosomes (backwards in the sense that time or space is usually
considered in HMMs) for i = 2, . . . , ⌊µ⌋ and terminating in a symmetric manner to compute
Pr (yˆd,1, yˆc,1, . . . , yˆd,⌊µ⌋, yˆc,⌊µ⌋|xµ).
We then obtain the probability of all the data by computing
Pr (yˆ) = Pr (yˆd,1, yˆc,1, . . . , yˆd,L, yˆc,L)
=
∑
xµ
(
Bin (xµ, nd, ρ) Pr (yˆd,1, yˆc,1, . . . , yˆd,⌊µ⌋, yˆc,⌊µ⌋|xµ)
Pr (yˆd,⌈µ⌉, yˆc,⌈µ⌉, . . . , yˆd,L, yˆc,L|xµ)
)
(19)
Restoring the conditioning that has been implicit throughout this section, (19) is Pr (yˆ|µ, τ, ρ),
the probability of all the data conditional on (µ, τ, ρ) and marginal to (a1, . . . , aL) and
(π1, . . . , πL),.
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3.4. Marginal Posteriors for µ, τ and ρ and Model Probabilities
The posterior for µ, τ and ρ, up to a normalising constant, is obtained simply by
multiplying (19) by the relevant priors.
Pr (yˆ, µ, τ, ρ) = Pr (yˆ|µ, τ, ρ) Pr (µ) Pr (τ) B (ρ, R1, R0) (20)
so
Pr (µ, τ, ρ|yˆ) = Pr (yˆ|µ, τ, ρ) Pr (µ) Pr (τ) B (ρ, R1, R0) 1
Pr (yˆ)
. (21)
Summarising this posterior is not entirely trivial for large data sets, because computing the
posterior at any given point (µ, τ, ρ) using the propagation algorithm of section 3.3 takes on
the order of Ln2d operations (and all addition has to be done in log-space, see e.g. Durbin
et al. (1998 p.77–78)), so we cannot rely on being able to make an arbitrarily large number
of such computations.
I use Cartesian product quadrature (CPQ; see e.g. O’Hagan and Forster 2004 9.43–
9.44) to compute marginal posteriors for each of µ, τ or ρ, and the normalising constant or
marginal likelihood Pr (yˆ) assuming there is a disease QTL. CPQ makes the approximation
Pr (yˆ) =
∫ ∫ ∫
Pr (yˆ, µ, τ, ρ) dµ dτ dρ
≃
∑
j
∑
k
∑
ℓ
w
(µ)
j w
(τ)
k w
(ρ)
ℓ Pr (yˆ, µj, τk, ρℓ) (22)
where e.g. j indexes a set of design points {µ1, µ2, . . .}, and w(µ)j is a weight associated with
the j-th design point. (A quantity proportional to) the marginal posterior for any variable
µ, τ or ρ is obtained by omitting the respective sum from (22). When computed using
priors describing our beliefs about these variables given that there is a QTL in the region of
interest, the quantity in (22) will be called Pr (yˆ|QTL).
The choice of design points and weights depends on the region of interest and the prior,
and the quadrature rule to be used. For example, all calculations in section 5 the region of
interest is µ ∈ (0, 1), measured in Mb or cM. With a uniform prior for µ, exponential prior
for T with T = 1/1000, and flat beta prior for ρ with R1 = R0 = 1, I used 100 design points
for each variable as follows:
µj = (j + 1/2) /100, w
(µ)
j = 0.01, j = 0, 1, . . . , 99
τk = exp (k/11), w
(τ)
k = exp (k/11)/11, k = 0, 1, . . . , 99
ρℓ = (ℓ+ 1/2) /100, w
(ρ)
ℓ = 0.01, ℓ = 0, 1, . . . , 99 (23)
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Here the quadrature rule is very simple and corresponds approximately to the trapezoid rule
or two point Newton–Cotes rule.
A simple model with no QTL is to assume there are no blocks of i.b.d. haplotype, xi = 0
for all i. This corresponds to a degenerate prior at ρ = 0 (or the limits µ→ ±∞ or τ →∞).
The probability of the data under this model, Pr (yˆ|no QTL), is easily computed directly
from (11). The Bayes factor (BF) in favour of the model with a QTL is then
BF =
Pr (QTL|yˆ)
Pr (no QTL|yˆ)
/
Pr (QTL)
Pr (no QTL)
=
Pr (yˆ|QTL)
Pr (yˆ|no QTL) . (24)
In addition to its Bayesian interpretation, the BF (or any isotonic transformation thereof)
has good properties, from a classical frequentist perspective, as a test statistic to test the null
model with no QTL against the alternative with a QTL (O’Hagan and Forster 2004 ch.5,
Patterson et al. 2004). Tests based on the BF are admissible, which means that no other
test has greater power for all (µ, τ, ρ). There may be other tests that have greater power for
some (µ, τ, ρ), and are therefore also admissible, but it is “unusual and strange” to find an
admissible test that is not based on the BF computed using some prior. Furthermore, (up
to isomorphism) the BF uniquely maximises average power, when the averaging is done with
respect to the prior for (µ, τ, ρ) used to compute the BF. Of course, this theory only applies
when the model is correct, but we might hope that the most powerful test for an approximate
model would be approximately most powerful for a more realistic model. The BF is a sensible
way to combine information across many markers to produce a single test, and thus avoids
(or overcomes) the problematic need to correct for multiple testing (Patterson et al. 2004).
I have also implemented a Markov chain Monte Carlo (MCMC; see e.g. Gilks et al.
1996, Liu 2001) sampler, which uses the Metropolis–Hastings algorithm to sample from the
posterior density for (µ, τ, ρ). A proposal distribution that seems to work reasonably well is
to update a single variable, choosen at random with equal probability, using the following:
µ′ ∼ N (µ, (0.1(mL −m1))2)
t′ ∼ G(10, t/10)
r′ ∼ B (5r, 5(1− r)) (25)
Kernel based methods (see e.g. Silverman 1986) can then be used to estimate marginal
posteriors for each of the variables, and these seemed similar to the marginal posteriors
computed using CPQ in the cases I examined. However, standard numerical methods to
estimate the model probability Pr (yˆ) from the MCMC output (see e.g. O’Hagan and Forster
2004 10.46) converged very slowly and did not seem reliable.
In addition to the ease and reliability with which the normalising constant or BF can
be computed, CPQ offers substantial advantages over alternatives such as MCMC in low
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dimensional situations such as this one. There are no concerns about burnin or mixing.
CPQ makes efficient use of the evaluation of the posterior density at each design point.
We can investigate sensitivity to prior specification afterwards without redoing much of the
computation.
In this particular situation CPQ offers an additional advantage, that by traversing
the design points in a particular order many of the backards variables computed in the
propagation algorithm of section 3.3 it be stored and reused, and thus a CPQ algorithm
with n design points runs much faster than a MCMC algorithm with n samples. The details
are as follows: The posterior can be computed on all points on a three dimensional lattice
most efficiently by traversing the lattice with different values of τ in the outermost loop,
different values of µ in the middle loop, and different values of ρ in the innermost loop. This
is because each time ρ changes but µ and τ do not then only (19) has to be recomputed. Each
time µ changes but τ does not then (18) always has to be recomputed, and if the old and new
values of µ are separated by one or more typed SNPs then one or more columns of backwards
variables also have to be recomputed. If µ always increases then the b are all computed first
and then as the lattice is traversed extra columns of b′ are computed and columns of b
are simply discarded. Changing τ means that the transition probabilities (12) change and
everything has to be recomputed. The run time of the whole algorithm (propagation and
CPQ) scales quadratically in nd and linearly in L + dµ where dµ is the number of design
points used for µ. If a small map region is found to be interesting additional design points
can be added later at moderate cost.
The disadvantages of CPQ are that we learn little about the posterior until calculations
have been completed for all the design points, we may belatedly discover that our choice
of design points was not a good one, that MCMC may be more sensitive to very narrow
spikes containing substantial probability mass (these will be missed if they fall inbetween
the design points) and that CPQ will not scale well to higher dimensional spaces which we
might need to study if we elaborated the model.
4. Coalescent Simulation Model and Error Model
In this section I describe a more realistic model that was used to simulate datasets on
which to test the method described above in sections 2–3. I also describe a specific model
for errors in allele frequency estimation. Each simulated dataset was generated as follows.
First I used the mksamples program of Hudson (2002) to simulate a sample of 20,000
1Mb long regions, assuming the standard neutral coalescent model with population recom-
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bination rate 4Nec = 400 (Ne = 10, 000 assuming 1cM/Mb), and assuming the infinite sites
mutation model with population mutation rate 4Neµ = 10. (This is an unrealistically low
mutation rate, the idea is to simulate some of the SNPs in the region rather than all of
them.) Chromosomes were paired at random to generate a sample of 10,000 individuals.
One SNP with a minor allele frequency between 10% and 20% was chosen as the disease
QTL. The disease status of each individual was simulated assuming multiplicative risks, so
that γ01/γ00 = γ11/γ01 = g. Here γG is the penetrance (probability of having the disease)
given genotype G at the disease QTL, with 1 the minor allele. The parameter g is called the
allelic or genotype relative risk (see e.g. Risch and Merikangas 1996). Simulations for this
paper used values of g = 4 and g = 1. The penetrance of the wild type homozygote, γ00,
was set so that the marginal probability of having the disease was 0.02. (Thus the number
of case chromosomes nd was random with expectation 0.02× 10, 000× 2 = 400.) Data from
all nd/2 case individuals, and an equal number nc/2 of randomly chosed control individuals,
were used to make up the two pools.
Excluding the disease QTL, all simulated SNPs with a minor allele frequency greater
than 0.05 in the nc/2 individuals in the control pool were analysed, so the number of SNPs
L was also random. The estimated allele frequencies at each SNP and for each pool were
either assumed to be known exactly, or assuming that allele frequencies were estimated using
the lag between kinetic PCR growth curves (Germer et al. 2000), using
yˆ =
1
1 + 2∆Ĉt
× n . (26)
Here yˆ is shorthand for the estimated count of the 1 allele, n is the number of chromosomes
in the pool, ∆Ĉt = Ĉt(1)− Ĉt(0), and Ĉt(a) is the number of PCR cycles before the amount
of PCR product for allele a exceeds some threshold level (Germer et al. 2000). The model
for Pr (yˆ|y, e) is then as follows: Define the true lag ∆Ct = log2((n − y)/y), which is the
lag that would give the correct frequency when (26) was used. I assume that the observed
lag ∆Ĉt averaged across r experiments is normally distributed with mean ∆Ct and variance
σ2/r, where σ2 is the variance in lags across replicate experiments.
Using the Jacobian
dyˆ
d(∆Ĉt)
= ln (2)yˆ(n− yˆ) 1
n
(27)
we can write down the error model in the form required in (4) for the analysis,
Pr (yˆ|y, n, σ2, r) = n
ln (2)yˆ(n− yˆ)
1√
2πσ2/r
exp

−
(
ln
(
(n−y)yˆ
y(n−yˆ)
))2
2 ln (2)2σ2/r

 . (28)
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5. Testing the Method
All measurements of the performance of the Bayesian method described in sections 2–
3 are based on analyses of datasets simulated under a more realistic model, as described
in section 4. Results are reported for two situations, either where the allele frequencies in
each pool are known exactly, or where there are errors in allele frequency estimation using
(28) and assuming that n, r = 2 replicates and σ = 0.2 PCR cycles are all known. This
magnitude of error is comparable to those reported by Germer et al. (2000) and Shiffman
et al. (2004). Using (27) we can say that these parameter values correspond to a “typical”
error in allele frequency estimate yˆ/n of about y/n(1−y/n) ln (2)σ/√2 ≃ y/n(1−y/n)0.098
or, for intermediate allele frequencies, about 2.5%.
For each situation, allele frequencies known either exactly or estimated with errors, I
analysed 500 datasets simulated assuming there was a QTL with a genotype relative risk
g = 4, and 500 datasets simulated assuming a null model with no QTL (g = 1, so the
penetrances γ00 = γ01 = γ11 = 0.02 are all equal). In these simulations, the median number
of case or control individuals, nd/2 = nc/2, was 200 (interquartile range 191–209, range
154–248). The median number of SNPs, L, was 28 (interquartile range 24–32, range 12–51).
These simulations assumed relative risks that are higher, and correspondingly sample sizes
that are smaller than may be realistic for many studies of QTLs influencing complex genetic
diseases. This reflects the need to analyse a reasonably large number of simulated datasets
with the computing resources currently available to me. The mean time to run an analysis on
a simulated dataset, using CPQ with the design (23) which requires evaluating the posterior
at 106 points on a 100×100×100 lattice, was about 36 minutes on a 2.4GHz Intel r© XeonTM
processor (totalling about 50 processor days for all the simulated datasets).
The inferences from the Bayesian method described here are compared against simple
but widely used classical single point analyses. When allele frequencies in each pool are
known exactly, a chi squared test can be used on the counts of the two alleles in the two
pools (see e.g. Clayton 2001), at each marker SNP separately. Visscher and Le Hellard (2003)
consider how to perform an equivalent test when the errors in allele frequency estimates are
Gaussian. The relatively small Gaussian errors in ∆Ĉt simulated here will produce errors
in allele frequency estimates that are approximately Gaussian (to the extent that (26) is
linear, and in fact are underdispersed relative to a Gaussian in the direction of extreme
allele frequencies). Visscher and Le Hellard (2003) show that a “shrunk” test statistic is
approximately distributed as χ2(1). This shrunk statistic is equal to the ordinary χ
2 statistic
computed using a point estimate of the counts, times a factor 2Vs/(2Vs + Ve) where Vs is
the estimated sampling variance of the allele frequency due to sampling a finite number of
cases and controls, under the null hypothesis of equal allele frequency in cases and controls,
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and Ve is the variance of the allele frequency in either pool due to experimental error. Using
(27), for the simulations performed here this shrinking factor is (approximately, for small σ)
2
2 + (nd + nc)pˆ(1− pˆ) ln (2)2σ2/r
. (29)
where pˆ is the allele frequency estimated under the null hypothesis, i.e. by pooling the case
and control pools.
The most widely considered statistics from a classical single point analysis are as follows:
Let pmin be the smallest p-value of the L (shrunk) chi squared tests applied to a given dataset,
and let µˆmin p be the map position of the marker with the smallest p-value.
It is worth emphasising that all the tests described in the following sections concern the
classical sense performance of statistics computed from the Bayesian analysis. Strictly, the
Bayesian sense performance can only be tested by conducting a Bayesian analysis assuming
a more realistic model (or prior).
5.1. Power to Detect a QTL
In this section I compare the power of tests to detect a QTL. I consider two different
test statistics, and different methods of determining critical regions. The first test statistic
is 2 lnBF, twice the logarithm of the Bayes factor (24). The second test statistic is pmin×L.
Multiplying the smallest single point p-value by L achieves a simple Bonferonni correction
for multiple testing that makes the critical region independent of L. Critical regions were
determined either analytically (by arbitrary or approximate methods), or empirically (from
analyses of datasets simulated under the null model). I report the performance of tests with
nominal sizes of α = 0.05 and α = 0.01; a more general comparison is made in figures 2 and
3. For each test, the true size was estimated using 500 simulations under the null model with
genotype relative risk g = 1, i.e. where risk is independent of genotype at the QTL. The
power against an alternative with g = 4 was estimated using 500 simulations. For each test
I report the estimated size and power, along with exact 95% binomial confidence intervals
for their values.
From a Bayesian perspective, 2 lnBF > 0 indicates evidence in favour of the model with
a QTL over the model with no QTL. As tables 2 and 3 show, the test with this critical
region has small size and reasonable power. However, much more simulation work, for
different models and combinations of parameters, is required to establish the generality of
this result. Also, at least from a classical perspective it is desirable to be able to choose a
critical region according to the size (or perhaps power) that is desired.
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An arbitrary critical region is 2 lnBF > 2 ln (1−α
α
). I say arbitrary because this in fact
guarantees nothing about the classical sense error rate, but does bound the Bayesian sense
error rate: The posterior probability that there is no QTL is less than α, Pr (no QTL|yˆ) < α,
when the model, the prior Pr (QTL) = Pr (no QTL), and the prior for (µ, τ, ρ) are correctly
specified. It can be seen from tables 2 and 3 that these arbitrary critical regions give tests
with true sizes that are smaller than α. Such tests are therefore conservative. Causes may
include the simplified model used to compute the BF, the dependence of the BF on the prior
specification T , and the fact that the critical region bounds the Bayesian sense error rate
rather than controls the classical sense error rate. The use of these arbitrary critical regions
2 lnBF > 2 ln (1−α
α
) entails a loss of power due to the actual size of the test being smaller
than intended, so a better method for determining a critical region is desirable.
Assuming goodness of the χ2(1) approximation, with the shrinking factor (29), and using
simple Bonferonni correction, suggests an approximate critical region pmin × L < α. These
tests have true sizes equal to or slightly smaller than their nominal sizes, which is expected
because the Bonferonni correction is conservative. This effect is expected to increase in
severity as the marker density increases, because there will be a greater number of more
positively correlated tests.
Although these respectively arbitrary and approximate methods for determining critical
regions are not terribly accurate, and cannot be recommended, it is worth noting that there
is no clear difference in power between the two test statistics, for tests with the same nominal
size. Since the test based on 2 lnBF is more conservative, it might reasonably be preferred.
It is not very meaningful to compare the power of tests with different sizes. Therefore I
used simulations to estimate exact critical regions, so that the power of different tests with
true size α could be compared. For these tests, the estimated size is exactly equal to the
nominal size, because the same set of simulations are used to compute both values. Although
the critical region for α = 0.01 is unlikely to be well estimated using only 500 simulations, by
a simple symmetry argument this procedure still allows a fair comparison across the different
test statistics. In every case the test based on 2 lnBF is substantially more powerful than
the test based on pmin × L.
By combining simulations in which there is not and is a QTL, we can view test statistics
as classifiers, and ask how well they discriminate between the two cases. The receiver
operating characteristics (ROC) for the two statistics are compared in figures 2 and 3. The
ROC curves are equivalent to plotting estimated power (= sensitivity) against size of test
(= 1 − specificity) for all possible tests (in fact, only all tests with non-disjoint critical
regions). When viewed in this way, it can be seen that the BF based statistic is uniformly
equal to or superior to the minimum p-value based statistic. The advantage of the BF is
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greater when there are errors in allele frequency estimation. This may be because, when the
dataset is less informative, it may be more important to have a model based way to combine
information across SNPs.
For comparison, I have also plotted the ROC curves for a test statistic derived from the
nonparametric likelihood approach that I have described previously (Johnson 2005). This
nonparametric likelihood ratio (NLR) statistic is defined in the same way as the BF (24),
using the same value for Pr (yˆ|no QTL), but makes the approximation
Pr (yˆ|QTL) ≃
L∏
i=1
Pr (yˆd,i, yˆc,i|x∗i ) (30)
where (x∗1, x
∗
2, . . . , x
∗
L) is the set of hidden states in the HMM that maximise the proba-
bility (30) under an order restriction that they are either a weakly increasing sequence, a
weakly decreasing sequence, or a weakly increasing then weakly decreasing sequence. This
order restriction must be true regardless of the shape of the genealogy at the QTL. The NLR
statistic is not a very good approximation to the BF, in particular because it can never be
negative. As far as I know, there is no theoretical reason to believe that it should have good
properties as a test statistic. However, as figures 2 and 3 show, tests based on the NLR are
superior to tests based on pmin × L and are not clearly distinguishable from tests based on
the BF. For the simulated datasets studied here, once the lookup table of emmission proba-
bilities (11) has been computed, computing the NLR is over 104 times faster than computing
the BF. Furthermore, a Viterbi-like algorithm (see Durbin et al. 1998) for computing the
NLR has time complexity O(L× nd), compared with the CPQ algorithm for computing the
BF which has time complexity O((L+ dµ)× n2d).
It may concern some readers that the critical regions and sizes and powers of tests were
all estimated while allowing the numbers of cases, controls and marker SNPs all to vary across
simulations. To interpret results acquired in this way, a formal classical framework would
require us to view the genotype relative risk g as the single parameter, and the number of
case chromosomes nd and number of SNPs L as random variables. It is true that even in such
a framework we would normally wish to perform tests conditional on the values of ancilliary
variables such as nd and L that contain no information about whether there is a QTL in the
region. However, it is a feature (or weakness) of classical inference that one is often free to
choose whether to condition on any given variable (but see e.g. Jaynes 1976, Robinson 1979).
The present results therefore do have a sound classical interpretation. In any case, the small
number of simulations performed here do not allow the luxury of estimating critical regions
conditional on nd or L. The simulation procedure as used reflects a likely feature of real
datasets, that SNP density will be higher in regions of the genome where the genealogy is
deeper. To alter the simulation procedure so that all simulated datasets had the same value
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of L would require the introduction of an ad hoc algorithm to select the L markers to be
used from a larger number of candidates.
As shown in figure 4, the null distributions of both test statistics show a negative
relationship with L. The negative relationship is most pronounced for the 2 lnBF statistic,
for the situation where there are errors in allele frequency estimation. In this case a linear
regression of 2 lnBF on L had a slope significantly different from zero (p = 0.010), and if the
values of 2 lnBF are partitioned into two groups according to the rank of L, the hypothesis
that they are drawn from the same distribution can be rejected using a Kolmogorov–Smirnov
test (p = 0.004). These tests do not detect significant dependence (p > 0.05) for the 2 lnBF
statistic when the allele frequencies are known exactly, or for the pmin × L statistic.
Although the simulations described here are adequate for demonstrating the superiority
of the BF based test over the pmin based test, we should be cautious about extrapolating
from the current results. In particular, it seems that the arbitrary (2 lnBF > 2 ln (1−α
α
))
or approximate (Bonferonni) critical regions described above will become more conservative
as SNP number or density increases. Performing tests that are not conditioned on SNP
number and density will introduce recognisable subset biases (see e.g. Robinson 1979). In
a real situation, a critical region should be determined using simulations conditioned on as
many ancilliary statistics of the observed data as possible, although for complex simulation
models it may be a matter of guesswork which statistics are approximately ancilliary. An
approach that could be most useful in practice is a variant of the permutation test of Churchill
and Doerge (1994). This could be applied if there were matched pairs of pools of cases and
controls, and each pair were typed in separate DNA pooling experiments (Shiffman et al.
2004). Then the phenotype labels could be permuted within each pair, giving a set of
equiprobable values for any test statistic under the null hypothesis. Such an approach could
not be explored here because it would require too much computation.
5.2. Sensitivity to prior specification
It is important to appreciate that the Bayes factor does not depend on the prior probabil-
ities for the two models (QTL or no QTL), but does depend on the priors for the parameters
within the QTL model. Misspecification of these priors could adversely influence the perfor-
mance of the BF as a test statistic, and it is important to examine typical levels of robustness
to the prior. To explore this, I compare the analyses above that used relatively flat generic
priors to analyses that used priors that were in a way optimised for the simulated datasets
under consideration.
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Note that the prior for µ is correct, but that the approximate model here uses two
other parameters τ and ρ that do not have any direct correspondance to parameters of the
coalescent model that the data were simulated under. It is therefore difficult to say what
the best prior is for analysing the simulated datasets. Loosely speaking, we might imagine
that for any one simulated dataset, in the limit of an infinite amount of informative data
the posterior for τ or ρ would converge to a single value, which we could call the “best
approximating” value for that dataset. However, with less than an infinite amount of data
the posterior mean for either variable would lie somewhere between the prior mean and
the best approximating value. Thus the distribution of posterior means across simulations
would be (very loosely speaking) inbetween the degenerate distribution at the prior mean,
and the distribution of best approximating values. Figure 5 shows that this is indeed the
case for µ, for which the prior mean is 0.5 and the true correct prior is uniform on [0, 1]. The
distributions of posterior means for τ and ρ shown in figure 5 suggests a lognormal prior for
τ (with ln (τ) having prior mean 6.8 and prior standard deviation 0.74) and a beta prior for
ρ (with R1 = 3.2 and R0 = 7.8, ρ having prior mean 0.29). Here I am assuming independent
priors. Note that this exercise in prior specification was totally ad hoc.
As can be seen in figures 2 and 3, the ROC of the test statistic 2 lnBF computed using
these priors is hardly different better than that using the original priors. The power for tests
of sizes α = 0.05 and α = 0.01 is not significantly different, based on 500 simulations. This
suggests that the performance of the BF as a test statistic, for these datasets, is quite robust
to prior specification within the QTL model.
Because most of the computation in QPQ can be reused, computing the BF for a dif-
ferent prior took on average less than three minutes, compared with the 36 minutes required
to compute the BF for the original prior.
5.3. Estimation of QTL Position
Figures 6 and 7 show analyses of four randomly chosen simulated datasets with QTLs
(g = 4). These illustrate the fact that these datasets contain only weak information about
the position of the QTL (or at least that the Bayesian method described here only extracts
weak information). It nonetheless seems worthwhile to examine how much information is
present.
It has been suggested that the map position of the marker with the most significant single
point test result (i.e. the minimum p-value) would be a “good” point estimate for the position
of the QTL (Kaplan and Morris 2001a,b). However, I point out that it is asymptotically
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inadmissible for a model very similar to the one assumed here. This argument considers the
limit of a QTL of small effect. One can imagine models where the position of the marker
with the minimum p-value, µˆmin p, will be tend to become uniformly distributed on (0, 1),
independent of the true value of µ, as the effect of the QTL tends to zero. The estimator µˆmin p
then has expected loss µ(1−µ)+ 1
2
under absolute error loss and 1
3
−µ(1−µ) under squared
error loss. The estimator µˆ = 1
2
has uniformly lower expected loss, |1
2
− µ| under absolute
error loss and (1
2
− µ)2 under squared error loss. This argument does not technically apply
for the model simulated here because SNPs (including the QTL) tend to be concentrated in
regions where the genealogy is deepest, so even completely ignoring the genotype data, the
position of any SNP is informative about the positions of all other SNPs including the QTL.
It does however suggest that better point estimates may be found, and suggests what their
asymptotic behaviour ought to be, at least approximately.
The performance of different methods for estimating the position of the QTL was as-
sessed using the 500 simulations with g = 4, for the two situations with and without errors in
allele frequency estimation. Due to the nature of the simulations performed here, the errors
reported are averaged over the distribution of the true value of µ. They are therefore not
classical expected losses in the strict sense, but expected losses averaged with respect to a
distribution of parameter values. Bayesian point estimators have uniquely best performance
when measured in this way (O’Hagan and Forster 2004 ch.5); the theory requires that the
model and prior are both correct. In particular, under squared error losses the average ex-
pected loss is minimised by the posterior mean, and under absolute error losses the average
expected loss is minimised by the posterior median. As shown in table 4, point estimators
derived from the posterior calculated using the Bayesian method described here are superior
to µˆmin p, the map location of the marker with the smallest p-value. When allele frequencies
in each pool are known exactly the Baysian analysis produces a 21% reduction in root aver-
age mean squared error and a 13% reduction in average mean absolute error. When there are
errors in allele frequency estimation the figures are similar, 18% and 11% respectively. The
nonparametric method developed previously by me (Johnson 2005) produces point estimates
that are competitive with the Bayesian method under squared error losses.
Figures 8 and 9 show results from the 500 datasets simulated with g = 4. The coverage
of credibility intervals constructed from the marginal posterior for µ falls well below nominal
levels. This suggests strongly that the simple model used for the analyses is not a good
approximation to the more realistic model the data were simulated under. One way to
improve the model would be to allow a more realistic model for the shape of the genealogy
at the QTL. To explicitly model this genealogy and hence the joint distribution of breakpoints
between ancestral and nonancestral chromosome would require something like the MCMC
sampler of Rannala and Reeve (2001) or Morris et al. (2002). Although taking such an
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approach is highly desirable, it may not scale well to large datasets and it seems worthwhile
to investigate approximations.
One approximation is the “pairwise correction” derived by McPeek and Strahs (1999)
and justified by them by the use of a quasi-score function, and used in a Bayesian context
by Morris et al. (2000). Essentially, this involves flattening the likelihood function by raising
all likelihoods to a power wn = (1 + (n − 1)cn)−1 < 1. Here cn is the pairwise correlation
over sampled chromosomes of the conditional score function for the position of the QTL.
An expression for cn for a coalescent model is given in appendix D of McPeek and Strahs
(1999). The n in this equation (which cn also depends on) is the number of chromosomes
carrying the QTL. It is not at all clear whether or how this correction should be applied in
the present context, because (i) as noted by Morris et al. (2000) the quasi-score justification
used by McPeek and Strahs (1999) does not apply in a Bayesian setting, (ii) in the present
work the likelihood is never written as a conditional product across chromosomes carrying
the QTL, (iii) it is not known how many chromosomes carry the QTL, and (iv) in my
computational implementation no proper likelihoods are ever calculated, only likelihoods
marginal to (π1, . . . , πL). However, the following ad-hoc approach does produce corrected
credibility intervals that achieve coverage very close to their nominal levels. The procedure
is to first estimate n by ndE(ρ), the product of the number of case chromosomes and the
posterior expectation of ρ, and then to flatten the marginal posterior for µ by raising it to a
power wn and renormalising. For the simulations performed here, wn had median 0.56 and
interquartile range 0.48–0.63. When this procedure was applied, good agreemement between
nominal and achieved coverage is obtained (figures 8 and 9). This suggests that the most
serious misspecification of the current model is the assumption of a star shaped genealogy,
rather than the assumption of linkage equilibrium in nonancestral blocks or the absence of
the disease variant in the control pool.
5.4. Application to real data
It is not really possible to examine the effectiveness of the Bayesian method described
here on real data, due to a lack of relevant published datasets. Primarily for the purpose
of comparison with other fine scale mapping methods, I have applied it to the dataset of
Hosking et al. (2002), and to quasi-synthetic datasets generated from that dataset. Hosking
et al. (2002) collected data using individual genotyping. In order to pretend that the data
were acquired using DNA pooling, I use a hypergeometric error model to relate the observed
counts with missing data to the underlying full data that were not observed. This assumes
the data are missing at random within and across SNPs.
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To my knowledge, no fine scale mapping method has been published that does not
perform well on the data of Hosking et al. (2002). Therefore, observing that the present
method performs acceptably, as shown in figure 10, is not necessarily encouraging. To
simulate a disease with a complex genetic basis, I generated three datasets by randomly
relabelling controls as cases with probability 10%, 20% or 30%. As shown in figure 10, on all
four datasets 95% credibility intervals covered the true location of the CYP2D6 gene after
the correction factor of (McPeek and Strahs 1999) had been applied to flatten the posterior.
This provides weak evidence that the method developed here may be reliable for mapping
QTLs from real data.
6. Discussion
In this paper I have described and tested a Bayesian method for detecting and mapping
a QTL, using multilocus data collected using DNA pooling within two trait groups.
Relatively recently, likelihood based fine scale mapping methods have been developed for
genotype data that build on previous haplotype based analyses by treating the unobserved
haplotypes as missing data and integrating over all possible haplotypes that are consistent
with the observed genotypes. This integration can be performed either using Markov chain
Monte Carlo (MCMC) (Liu et al. 2001, Reeve and Rannala 2002, Morris et al. 2003) or
using exact numerical methods for hidden Markov models (Zhang and Zhao 2002). Data
from DNA pools are estimated counts of alleles at each locus with no phase information.
Fine scale mapping from genotype data and from DNA pools can in theory be regarded as
closely related missing data problems.
The approach taken in this paper combines elements of the approaches of Zhang and
Zhao (2002) and of Morris et al. (2000) and Liu et al. (2001). Like Zhang and Zhao (2002), I
use a model that is sufficiently simple that I can use hidden Markov model (HMM) methods
to sum over all possible haplotypes that are consistent with the observed data. However,
after computing the likelihood using a propagation algorithm, Zhang and Zhao (2002) then
maximise that likelihood with respect to the remaining model parameters. In contrast and
like Morris et al. (2000) and Liu et al. (2001), I embed the HMM within a fully Bayesian
approach and compute posterior probability distributions for the quantities of interest.
One advantage of a Bayesian approach is that probability statements can be made di-
rectly about quantities of interest. For example, we can state the probability that there
is QTL in any given region, including the whole region under study. Thus, mapping and
detecting a QTL are intimately related aspects of the same analysis. They are different infer-
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ences that are made from the same posterior probability distribution. Within the Bayesian
framework there is no need to choose between a bewildering array of estimators, test statis-
tics and methods for correcting for multiple testing; the approach has a pleasing simplicity,
at least conceptually.
However, the probabilities computed in a Bayesian analysis are only meaningful if the
model and prior are realistic. The Catch-22 is that in order to compute Baysian posterior
probabilities, I had to assume a model that was worringly oversimplified and not very believ-
able. The present work is therefore best regarded as a step towards Bayesian analysis of data
collected using DNA pooling. It may be helpful to draw parallels with methods for analysis
of genotype data (collected using individual typing). Sadly, the present method allows us
to make inferences assuming a model less elaborate than the one of Morris et al. (2000),
whereas we might aspire to being able to assume a model like the one of of Morris et al.
(2002) or Zollner and Pritchard (2005). However, Bayesian analysis of such realistic models
has required Markov chain Monte Carlo (MCMC) to integrate over high dimensional spaces
of auxiliary variables or missing data. Such computationally intensive approaches may have
difficulty handling large datasets. In contrast, the method described here is relatively fast,
and large datasets could be analysed with realistic computational resources. For example, 27
processor-days would be required to analyse data from a whole genome scan with 100 cases,
500,000 SNPs, and evaluation of the posterior at points 50kb apart. In contrast, Zollner
and Pritchard (2005) estimate that their MCMC based procedure for data from individual
typings would take 85 processor-years for the same scale of analysis. A further advantage of
avoiding Monte Carlo methods is that the large numbers of analyses needed for a sliding win-
dow analysis, or a permutation test, can be performed without needing human intervention
to adjust mixing parameters or monitor convergence. Finally and perhaps most significantly,
I am able to compute a Bayes factor (BF) to compare models in which there is, and is not,
a disease QTL in the whole region of interest. To my knowledge, no association mapping
method using genotype data is able to do this, although Patterson et al. (2004) are able to
compute a BF for admixture mapping using genotype data.
There is a Bayesian justification for the present method. (“This is the best model for
which a Bayesian analysis of data from DNA pools is currently possible.”) However, serious
concerns about model inadequacy (“Well, that model simply isn’t good enough!”) mean
that, in this paper, I have mostly focussed on the classical frequentist justification. Us-
ing simulations assuming a more realistic model, I have shown that the present method is
uniformly superior to classical single point methods of analysis. Single point methods are
the most obvious way to analyse data collected using DNA pooling, although composite
likelihood methods (Terwilliger 1995, Xiong and Guo 1997, Collins and Morton 1998, Ma-
niatis et al. 2004, 2005) could also be used. The simulation results demonstrate that the
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BF computed using the present method makes a more powerful test for the presence of a
QTL than the minimum p-value from single point tests, that the posterior density for the
position of the QTL leads to a better point estimator than the position of the marker with
the minimum p-value, and that well calibrated credibility intervals can be derived from the
posterior density for the position of the QTL, after applying the correction of McPeek and
Strahs (1999).
The performance of composite likelihood (CL) methods was not examined here. This
was because no CL method has been developed that allows errors in allele frequency esti-
mation, and because, to my knowledge, no CL method assumes a model that is obviously
more realistic than the model assumed by the present method. In particular, all CL methods
implicitly assume linkage equilibrium in non-ancestral blocks of chromosome. In the nota-
tion of the present paper, CL methods assume that the number of chromosomes carrying
ancestral haplotype at the i-th SNP, xi, is conditionally independent across SNPs. Even a
poor model that does capture some aspect of the dependence across SNPs, such as the star
shaped genealogy assumed here, seems preferable. To my knowledge, there is no CL method
that produces well calibrated confidence or credibility intervals. Perhaps because of this,
Maniatis et al. (2005) state that “[t]he main objective in positional cloning is to estimate the
kb location of a causal SNP as accurately as possible, with its support interval an important
but secondary objective.” However, it seems to me that we should focus on methods for
computing well calibrated credibility intervals, and ideally a well calibrated posterior den-
sity. The acid test is to ask whether a statistical method informs us about what is a good
action or decision to be taken subsequently. A point estimate for QTL position, without a
reliable measure of precision, is not very helpful for planning future experiments to further
refine the position of that QTL.
One of the more surprising results is that, in the simulations performed here, the non-
parametric likelihood ratio (NLR) test derived from the method proposed previously by me
(Johnson 2005) is basically as powerful as the BF for detecting a QTL. This is surprising
because there is no theoretical basis for the NLR test statistic, but a strong theoretical basis
for the BF test statistic. Since the NLR can be computed much more quickly, both in abso-
lute and complexity terms, its performance in simulations over a wider range of parameters
will be examined in a subsequent paper.
Given that the NLR performs as well as the BF for detecting a QTL, but that the BF
is much more expensive to compute, one might reasonably ask what are the benefits of the
Bayesian method described here. Firstly, the BF has a Bayesian interpretation, and since
it can be negative it can indicate Bayesian sense evidence in favour of there being no QTL.
The NLR test statistic can never be negative, has no direct Bayesian interpretation, and
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is not a good approximation to the BF. Secondly, the posterior median from the Bayesian
method provides superior point estimates under absolute error losses. Thirdly, the Bayesian
method produces well calibrated credibility intervals, but the profile likelihood method I
proposed previously does not (see figure 4 of Johnson 2005). Finally, the unconditional cov-
erage frequencies of credibility intervals say nothing about the conditional or Bayesian sense
performance of a method. For multistage QTL mapping experiments we should probably
guide our choice of where to type further markers using the typically complex, heavy tailed
and often multimodel posterior distributions computed using the Bayesian method described
here, as exemplified in figure 7. If analysing data from a whole genome scan, I would recom-
mend a multistage analysis that first uses the NLR statistic to identify regions of interest,
and the to use the CPQ algorithm to compute Bayes factors and posterior distributions for
QTL position within those regions.
Given the large number of simplifications made in specifying the model used here,
one might wonder why the method works at all. The three most obviously inadequate
approximations are the star shaped genealogy, the absence of the disease allele in the control
pool, and the assumption of linkage equilibrium in non-ancestral blocks of chromosome. I
will briefly discuss these inadequacies in turn.
Figures 8 and 9 show that credibility intervals only achieve prescribed coverage levels
when a correction is made for the genealogy not in fact being star shaped. This suggests
a serious inadequacy of the model. This is further supported by the observation of the
very similar ROC curves in figures 2 and 3 for the theoretically optimal BF (assuming a star
shaped genealogy), and the NLR statistic that has no theoretical basis (but allows any shape
genealogy; Johnson 2005). Addressing this inadequacy is likely to lead to greater power to
detect a QTL, and perhaps smaller credibility intervals of a given size. However, it will
be hard to achieve without imposing a substantial computational burden. In particular, it
may become difficult to compute the BF test statistic if MCMC is used to integrate over
genealogies at the QTL.
Although it is conceptually straightforward to allow blocks of ancestral chromosome
in the control pool, this would increase the number of hidden states at each SNP from
(nd + 1) to (nd + 1)(nc + 1). Since the propagation algorithm (section 3.3) requires time
that is quadratic in the number of hidden states, the analysis would be intractable using
the current approach. As an alternative, any number of separate pools could be treated
as conditionally independent HMMs, but then we would have to integrate over the high
dimensional space of allele frequencies and ancestral haplotypes using MCMC or importance
sampling (see below).
It is possible that the current model adapts to fit there being blocks of ancestral chro-
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mosome in the control pool, by appropriate adjustment of the allele frequency parameters.
Ancestral blocks that are explicitly modelled in the disease pool would then represent ad-
ditional blocks beyond what would be expected according to the adjusted allele frequency
parameters. If this was so, the parameter ρ might be best interpeted as representing the
rate of excess disease alleles in the disease pool.
Since only marginal observations are available, the assumption of linkage equilibrium
may be relatively innocuous. Since there is virtually no information in the data about
linkage disequilibrium, introducing parameters describing linkage disequilibrium into the
model might have little effect on inferences about the quantities of interest. It is possible
to retain the present framework where all the data are modelled as a single HMM, but to
include pairwise linkage disequilibrium by allowing allelic state along each chromosome to
be a first order Markov chain (see e.g. Liu et al. 2001, Morris et al. 2002). This will be quite
computationally expensive, but could be examined in the future.
For the parameters chosen for the simulations performed here, the benefits of the present
Bayesian method are somewhat modest. It remains unclear whether there would be larger
benefits for other values of the simulation parameters, in particular more SNPs in the dataset,
and/or larger benefits from a Baysian analysis with a more realistic model. Clarification of
both points awaits access to substantial computational resources. It is worth commenting
that many of the variables in the present model also feature in more elaborate models, and
therefore the present approach could be used to generate (for example) a joint importance
sampling distribution for the ancestral haplotype, allele frequencies, and age and position of
the QTL.
Even the simulated datasets studied here were generated under a model that lacks
realism in several respects. For example, in simulating errors in allele frequency estimation I
have ignored differential amplification of the two alleles, which may cause estimates of allele
frequencies obtained using DNA pools to be biased. This manifests itself as only a second
order effect on the difference in allele frequency between case and control pools (Visscher
and Le Hellard 2003). Differential amplification can be accomodated easily in the present
method of analysis, for example by making yˆd,i a vector consisting of data from the pool
and also from heterozygous individuals or pools of known composition. Even if no data
from heterozygotes is available, it is possible to compute a Pr (yˆ|y) by integrating over a
distribution of differential amplification constants, like in the approach of Moskvina et al.
(2005).
One feature of the posteriors calculated using the present method (and especially after
McPeek and Strahs (1999) flattening) is that they are very heavy tailed, and so large cred-
ibility intervals (99%, 99.9%) tend to be very wide, perhaps almost as wide as credibility
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intervals computed from the prior! This suggests that, if a series of fine scale mapping ex-
periments were conducted using DNA pooling, we would not be making radical reductions in
the size of the region under study at each stage, but rather would be increasing the density
of markers in some regions more than others after each stage of analysis.
Software
A software package implementing the methods described here is available from the web
site http://homepages.ed.ac.uk/tobyj/software/ . Source code is available and the
package can be distributed freely under the terms of the GNU general public licence (Free
Software Foundation 1991).
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Table 1. Frequently used notations.
Symbol Meaning
ai Allele present (0 or 1) on ancestral haplotype at i-th SNP
b,b′ Backwards variables, see (13) and (14)
B (α, β) Beta distribution with parameters α and β
Bin (n, p) Binomial distribution with parameters n and p
Bin (x, n, p) Probability of drawing x from a binomial distribution with parameters n
and p
BF Bayes factor
CPQ Cartesian product quadrature
dµ Number of design points used for µ in quadrature algorithm
ei Precision of assay used to genotype i-th SNP
E (λ) Exponential distribution with rate parameter λ (mean 1/λ)
g Genotype relative risk; factor by which disease allele increases penetrance
or risk
G (α, β) Gamma distribution with shape parameter α and scale parameter β
HMM Hidden Markov model
i Index of SNP, i = 1, . . . , L
i.b.d. Identical by descent
L Number of SNPs
mi Map position of the i-th marker
MCMC Markov chain Monte Carlo
nc, nd Number of chromosomes in control and case pools respectively
N (µ, σ2) Normal distribution with mean µ and variance σ2
NLR Nonparametric likelihood ratio, see (30)
pmin Smallest p-values out of L tests in single point analysis
Pi,a Prior parameter: πi(a) ∼ B (Pi,a, Pi,1−a)
r Number of experimental replicates used to estimate ∆Ĉt
R Prior parameter: ρ ∼ B (R1, R0)
ROC Receiver operating characteristics
T Prior parameter: τ ∼ E (T )
xi Number of chromosomes in case pool carrying ancestral i.b.d. haplotype
at i-th SNP
xµ Number of chromosomes in case pool carrying ancestral i.b.d. haplotype
at position of QTL
yc,i(a) True count of allele a at i-th SNP in control pool
yd,i(a) True count of allele a at i-th SNP in case pool
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Table 1—Continued
Symbol Meaning
yˆc,i(a) Estimated count of allele a at i-th SNP in control pool
yˆd,i(a) Estimated count of allele a at i-th SNP in case pool
yˆ Shorthand for yˆc,i(1) or yˆd,i(1) for some i
yˆ All the data
α Nominal size (rate of type I error) of a test
∆Ĉt Estimated lag between PCR growth curves used to type DNA pool
γG Penetrance (risk of disease) for genotype G at the QTL
µ Map position of the disease locus
µˆmin p Map position of SNP with smallest p-value in single point analysis
πi(1) Expected frequency of allele 1 at i-th SNP in non-ancestral chromosome
ρ Expected frequency of disease allele in case pool
σ Standard deviation of experimental error in estimation of ∆Ĉt
τ Age of the disease allele
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Table 2. Performance of tests to detect a disease QTL, when allele frequencies in each
pool are known exactly.
Statistic Method Nominal size Critical value True size Power
2 lnBF Arbitrary 0 0.080 0.870
(0.058, 0.107) (0.837, 0.898)
2 lnBF Arbitrary 0.05a 5.889 0.010 0.710
(0.003, 0.023) (0.668, 0.749)
pmin × L Bonferonni 0.05 0.05 0.040 0.720
(0.025, 0.061) (0.678, 0.759)
2 lnBF Simulation 0.05 0.903 0.050 0.842
(0.033, 0.073) (0.807, 0.873)
pmin × L Simulation 0.05 0.063 0.050 0.740
(0.033, 0.073) (0.699, 0.778)
2 lnBF Arbitrary 0.01a 9.19 0.002 0.628
(0.000, 0.011) (0.584, 0.67)
pmin × L Bonferonni 0.01 0.010 0.000 0.582
(0.000, 0.006) (0.537, 0.626)
2 lnBF Simulation 0.01 5.864 0.010 0.710
(0.003, 0.023) (0.668, 0.749)
pmin × L Simulation 0.01 0.027 0.010 0.664
(0.003, 0.023) (0.621, 0.705)
anot a nominal size in the classical sense but a nominal upper bound on the Bayesian sense
error rate
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Table 3. Performance of tests to detect a disease QTL, when there are errors in allele
frequency estimation with r = 2 replicates and σ = 0.2 PCR cycles.
Statistic Method Nominal size Critical value True size Power
2 lnBF Arbitrary 0 0.080 0.782
(0.058, 0.107) (0.743, 0.817)
2 lnBF Arbitrary 0.05a 5.889 0.008 0.532
(0.002, 0.020) (0.487, 0.576)
pmin × L Bonferonni 0.05 0.05 0.040 0.560
(0.025, 0.061) (0.515, 0.604)
2 lnBF Simulation 0.05 0.723 0.050 0.746
(0.033, 0.073) (0.705, 0.784)
pmin × L Simulation 0.05 0.085 0.050 0.642
(0.033, 0.073) (0.598, 0.684)
2 lnBF Arbitrary 0.01a 9.19 0.000 0.424
(0.000, 0.006) (0.380, 0.469)
pmin × L Bonferonni 0.01 0.01 0.010 0.432
(0.003, 0.023) (0.388, 0.477)
2 lnBF Simulation 0.01 4.28 0.010 0.596
(0.003, 0.023) (0.552, 0.639)
pmin × L Simulation 0.01 0.01 0.010 0.432
(0.003, 0.023) (0.388, 0.477)
anot a nominal size in the classical sense but a nominal upper bound on the Bayesian sense
error rate
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Table 4. Performance of point estimators of QTL position.
Estimator Average expected loss under
squared error losses absolute error losses
Allele frequencies known exactly
µˆmin p 0.208
2 0.120
Mean (µ|yˆ) 0.165 2 0.107
Median (µ|yˆ) 0.166 2 0.105
NP method 0.165 2 0.112
Errors in allele frequency estimation
µˆmin p 0.239
2 0.146
Mean (µ|yˆ) 0.195 2 0.132
Median (µ|yˆ) 0.203 2 0.130
NP method 0.198 2 0.136
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when there are errors in allele frequency estimation, with σ = 0.2 and r = 2.
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10 Analysis of data of Hosking et al. (2002; top panel), and quasi-synthetic
datasets generated by randomly relabelling controls as cases with probability
10%, 20% or 30% (lower three panels, top to bottom). Points are − log10 (p)
from single point χ2 tests, and dashed and solid lines are the marginal pos-
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Fig. 1.— Hierachical or Bayesian network structure of the model. The region inside the
rectangle is duplicated for each of L SNPs. Lines indicate the dependence structure of the
model: Variables not connected are independent, conditional on all other variables in the
model.
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Fig. 2.— Sensitivity vs. specificity for 2 lnBF (solid line) and pmin × L (dashed line), when
allele frequencies in each pool are known exactly. The dotted line shows the performance of
2 lnBF computed using the priors obtained from figure 5, and the dot-dashed line shows the
performance of a nonparametric likelihood ratio test statistic (Johnson 2005; see text).
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Fig. 3.— Sensitivity vs. specificity for 2 lnBF (solid line) and pmin × L (dashed line), when
there are errors in allele frequency estimation with r = 2 replicates and σ = 0.2 PCR cycles.
The dotted line shows the performance of 2 lnBF computed using the priors obtained from
figure 5, and the dot-dashed line shows the performance of a nonparametric likelihood ratio
test statistic (Johnson 2005; see text).
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Fig. 4.— Sampling distribution of test statistics 2 lnBF (top) and pmin × L (bottom, on log
scale) under null model (g = 1), as functions of L, the number of SNPs in the simulated data
set. The 0.95 and 0.99 quantiles are shown as solid lines. The least squares linear regression
is shown as a dotted line. Results shown are for the situation where there are errors in allele
frequency estimation, but results are similar when allele frequencies are known exactly.
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Fig. 5.— Original priors (dotted lines) and distribution of posterior expectations (solid lines)
for the three parameters of the approximate model. This suggests more accurately specified
priors (dashed lines) as described in the text.
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Fig. 6.— Example simulated datasets with g = 4 and where allele frequences are known
exactly. Points are − log10 p for single point χ2 tests. Dotted lines are posterior density and
solid lines are posterior density with McPeek–Strahs correction. Vertical dashed lines show
position of disease QTL.
– 46 –
0 200 400 600 800 1000
0
0
1
2
0
2
3
0
4
1
6
1
8
2
10
2
3
3
position (kb)
Fig. 7.— The same simulated datasets as shown in figure 6, but with errors in allele frequency
estimation with σ = 0.2 PCR cycles and r = 2 experimental replicates. Points are − log10 p
for single point shrunk (Visscher and Le Hellard 2003) χ2 tests. Dotted lines are posterior
density and solid lines are posterior density with McPeek–Strahs correction. Vertical dashed
lines show position of disease QTL.
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Fig. 8.— Nominal and achieved coverage of credibility intervals for position of QTL, when
allele frequencies are known exactly. Credibility intervals were constructed either without
(dotted line) or with (solid line) the approximate correction factor of McPeek and Strahs
(1999).
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Fig. 9.— Nominal and achieved coverage of credibility intervals for position of QTL, when
there are errors in allele frequency estimation, with σ = 0.2 and r = 2. Credibility intervals
were constructed either without (dotted line) or with (solid line) the approximate correction
factor of McPeek and Strahs (1999).
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Fig. 10.— Analysis of data of Hosking et al. (2002; top panel), and quasi-synthetic datasets
generated by randomly relabelling controls as cases with probability 10%, 20% or 30% (lower
three panels, top to bottom). Points are − log10 (p) from single point χ2 tests, and dashed
and solid lines are the marginal posterior for disease gene position, without and with the
correction factor of (McPeek and Strahs 1999). Vertical dashed lines show the true position
of CYP2D6.
